Colony-stimulating factors: clinical status.
Gabrilove
J L
JL
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000741:Anemia, Aplastic / Q000628:therapy; D003115:Colony-Stimulating Factors / Q000502:physiology / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000502:physiology / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007377:Interleukin-3 / Q000502:physiology / Q000627:therapeutic use; D007958:Leukocyte Count / Q000187:drug effects; D016173:Macrophage Colony-Stimulating Factor / Q000502:physiology / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D009504:Neutrophils / Q000187:drug effects
D003115:Colony-Stimulating Factors; D007377:Interleukin-3; D016179:Granulocyte Colony-Stimulating Factor; D016173:Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor